Papers

8

Total Citations

106

H-Index

4

About

Dr. Cameron Stock is a leading thoracic surgeon whose research centers on advancing minimally invasive techniques for lung cancer and esophageal surgery, with a particular focus on comparing video-assisted thoracoscopic surgery (VATS) and robotic-assisted thoracic surgery (RATS). Their most impactful work, a 2021 study on conversion to thoracotomy during thoracoscopic versus robotic lobectomy (47 citations), identified key predictors and outcomes that guide surgical decision-making. Dr. Stock’s 2024 review, "The Surgical Renaissance" (25 citations), synthesizes how VATS and RATS have revolutionized patient outcomes through smaller incisions without compromising oncologic efficacy. Further contributions include demonstrating that surgeon experience significantly reduces prolonged air leaks after robotic lobectomy (16 citations) and analyzing trends in segmentectomy approaches for lung cancer (6 citations). Dr. Stock has also developed safe, reproducible techniques for emergency conversion from robotic thoracoscopy to thoracotomy, and advanced robotic approaches for mediastinal surgery and post-esophagectomy hiatal hernia repair. With a growing body of work totaling over 100 citations, Dr. Stock’s research is shaping the future of thoracic surgery by optimizing robotic and thoracoscopic approaches to improve patient safety and recovery.

Research Focus

Key Achievements

4
H-Index
8
Papers
106
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Conversion to Thoracotomy During Thoracoscopic vs Robotic Lobectomy: Predictors and Outcomes
47 citations · 2021
📈 Most Prolific Year: 2024 (4 Papers)
🤝 Key Collaborators: 27
🏛 Institutions: Tufts University, Lahey Hospital and Medical Center, Lahey Medical Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
    Robotic Mediastinal Surgery
    4 citations · 2022
  6. 6
  7. 7
  8. 8

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago